NasdaqCM - Delayed Quote USD
Exicure, Inc. (XCUR)
At close: November 6 at 4:00 PM EST
After hours: 7:09 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
500.0000
--
28,826.0000
-483.0000
16,613.0000
Operating Expense
6,466.0000
14,076.0000
30,657.0000
62,066.0000
42,049.0000
Operating Income
-5,966.0000
-14,076.0000
-1,831.0000
-62,549.0000
-25,436.0000
Net Non Operating Interest Income Expense
8.0000
32.0000
-580.0000
-1,550.0000
399.0000
Other Income Expense
-2,214.0000
-2,870.0000
38.0000
-3.0000
369.0000
Pretax Income
-8,172.0000
-16,914.0000
-2,373.0000
-64,102.0000
-24,668.0000
Tax Provision
--
--
209.0000
--
--
Net Income Common Stockholders
-8,172.0000
-16,914.0000
-2,582.0000
-64,102.0000
-24,668.0000
Diluted NI Available to Com Stockholders
-8,172.0000
-16,914.0000
-2,582.0000
-64,102.0000
-24,668.0000
Basic EPS
-0.90
-2.11
-0.56
-21.70
-8.40
Diluted EPS
-0.90
-2.11
-0.56
-21.70
-8.40
Basic Average Shares
8,655.9820
8,013.8400
4,619.4710
2,953.9010
2,906.7860
Diluted Average Shares
8,655.9820
8,013.8400
4,619.4710
2,953.9010
2,906.7860
Total Operating Income as Reported
-6,886.0000
-14,996.0000
-1,831.0000
-62,549.0000
-25,436.0000
Total Expenses
6,466.0000
14,076.0000
30,657.0000
62,066.0000
42,049.0000
Net Income from Continuing & Discontinued Operation
-8,172.0000
-16,914.0000
-2,582.0000
-64,102.0000
-24,668.0000
Normalized Income
-5,277.0000
-14,046.0000
-2,643.6200
-64,110.0000
-24,715.0000
Interest Income
14.0000
32.0000
15.0000
141.0000
972.0000
Interest Expense
6.0000
--
595.0000
1,691.0000
573.0000
Net Interest Income
8.0000
32.0000
-580.0000
-1,550.0000
399.0000
EBIT
-8,166.0000
-16,914.0000
-1,778.0000
-62,411.0000
-24,095.0000
EBITDA
-7,230.0000
-15,539.0000
78.0000
-60,632.0000
-22,648.0000
Reconciled Depreciation
936.0000
1,375.0000
1,856.0000
1,779.0000
1,447.0000
Net Income from Continuing Operation Net Minority Interest
-8,172.0000
-16,914.0000
-2,582.0000
-64,102.0000
-24,668.0000
Total Unusual Items Excluding Goodwill
-2,895.0000
-2,868.0000
78.0000
8.0000
47.0000
Total Unusual Items
-2,895.0000
-2,868.0000
78.0000
8.0000
47.0000
Normalized EBITDA
-4,335.0000
-12,671.0000
--
-60,640.0000
-22,695.0000
Tax Rate for Calcs
--
--
0.0002
--
--
Tax Effect of Unusual Items
--
--
16.3800
--
--
12/31/2020 - 5/22/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DRMA Dermata Therapeutics, Inc.
1.3500
+7.14%
SXTP 60 Degrees Pharmaceuticals, Inc.
0.9766
+8.26%
XRTX XORTX Therapeutics Inc.
1.4500
+1.40%
BCTX BriaCell Therapeutics Corp.
0.7050
-2.83%
AZTR Azitra, Inc.
0.4941
+2.77%
PBM Psyence Biomedical Ltd.
0.0612
-6.99%
ALZN Alzamend Neuro, Inc.
1.4500
-11.59%
REVB Revelation Biosciences, Inc.
0.8700
+2.57%
ADTX Aditxt, Inc.
0.4750
+0.30%
FRES Fresh2 Group Limited
1.3864
-15.98%